GlassScriptPhysician profile
Carrie Kime
NPI 1598867723
$533.18
in general payments reported to CMS, 2019-2025
11 companies · $86.43 in 2025
The $86.43 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $29.77 · 2022: $57.90 · 2023: $264 · 2024: $94.86 · 2025: $86.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $426 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $425.51 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $285.08 | 2023-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Paratek Pharmaceuticals, INC. | $42.61 | 2021-2022 | |
| Cardinal Health 414 LLC | $35.50 | 2024 | Kit For The Preparation of Lymphoseek (Technetium Tc 99m Tilmanocept) |
| Stryker Corporation | $28.40 | 2024 | Spy-Phi System |
| Kci USA, INC. | $27.72 | 2022 | |
| Alnylam Pharmaceuticals INC. | $23.14 | 2025 | Onpattro |
| Coopersurgical, INC. | $22.00 | 2025 | Onetrac Lx |
| Amgen INC. | $20.50 | 2023 | Repatha |
| Janssen Pharmaceuticals, INC | $17.79 | 2023 | Xarelto |
| Myriad Genetic Laboratories, INC. | $17.34 | 2022 | |
| Medtronic, INC. | $13.10 | 2024 | Venaseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carrie Kime listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.